Amazon Malaria Initiative

News

AMI USAID
Closing Ceremony for the Colombia Malaria Project

April 25, 2015
Description: After five years of work, the Colombia Malaria Project came to an end. At the formal closing ceremony in Bogotá, responsibility for institutionalizing the achievements and lessons learned, as well as sustaining efforts against malaria to overcome challenges, was transferred to the Ministry of Health and Social Protection (MSPS), the National Institute of Health (INS), and the territorial entities, with support from AMI/RAVREDA partners. Read the news release and watch interviews with the former project manager, government officials, and PAHO/WHO advisors here (In Spanish).

World Malaria Day 2015

April 25, 2015
Description: The Amazon Malaria Initiative (AMI) recognizes the need for more research on malaria in pregnancy in Latin America and the Caribbean. The US Centers for Disease Control and Prevention (CDC) estimate that 4 in 100 pregnancies in the region are affected by malaria. The negative effects of malaria in pregnancy include prematurity, low birth weight, miscarriages, stillbirth, and congenital malaria in infants. In addition, malaria in pregnant women can result in anemia, an increased risk of severe malaria, and even death. As most of the region has a low incidence of malaria, intermittent preventive treatment in pregnancy (IPTp) is not recommended in Latin America and the Caribbean.


Detecting and treating malaria in pregnant women is important in order to defeat malaria in Latin America and the Caribbean. AMI partners such as the CDC recommend that pregnant women be screened for malaria at each antenatal care visit. Pregnant women who are diagnosed with malaria should receive differentiated treatment according to the treatment guidelines of each country. As with the general population, prompt and effective diagnosis is encouraged along with the use of insecticide-treated bed nets.


AMI has developed a set of region specific Strategic Orientation Documents with guidelines for malaria. The Strategic Orientation Documents cover the topics of drug resistance monitoring in low-incidence settings, vector control, pharmaceutical management, and medicine quality control. They can be found on the AMI Resources page and on the RAVREDA website. Click Here.

Malaria Partners' Meeting and XIV AMI/RAVREDA Annual Evaluation Meeting

March 23-26, 2015
Location: Rio de Janeiro, Brazil
Description: The Pan American Health Organization, in coordination with the Ministry of Health of Brazil, will host the annual AMI/RAVREDA international partners' meeting in Rio de Janeiro from March 24-26, 2015. The meeting's purpose is to review progress, lessons learned, and the implementation of tools developed by AMI/RAVREDA partners. Malaria-endemic countries' ministries of health that are on the frontlines of regional efforts against malaria will be present. Representatives of the United States Agency for International Development (USAID), US Centers for Disease Control and Prevention (CDC), US Pharmacopeial Convention (USP), the USAID-funded Systems for Improved Access to Pharmaceuticals and Services Program (SIAPS), and Links Media will attend on behalf of AMI/RAVREDA. Prior to the official opening, a Malaria Partners' Meeting is also planned with other entities such as the Mexican Agency for International Development Cooperation (AMEXCID), the Clinton Health Access Initiative (CHAI), Global Fund to Fight AIDS, TB, and Malaria, the Haiti Malaria Elimination Consortium (HaMEC), IS Global, and Population Services International (PSI).

Haiti Malaria Elimination Consortium (HaMEC) Is Formed

February 26, 2015
Description: The Bill and Melinda Gates Foundation has awarded a $29.9 million grant to the US Centers for Disease Control and Prevention to lead the new Haiti Malaria Elimination Consortium (HaMEC). HaMEC's objective will be to eliminate malaria from the island of Hispaniola by 2020. Eight other institutions make up the consortium. "We laud this expression of solidarity with efforts to eliminate malaria from the only two countries in the Caribbean [Haiti and the Dominican Republic] where transmission still exists..." said Dr. Keith Carter, Senior Advisor on Malaria and other Communicable Diseases with the Pan American Health Organization/World Health Organization, a consortium partner.

XIV National Malaria Research Meeting in Brazil

February 2015
Location: Sao Paulo, Brazil
Description: Brazil will host its XIV National Malaria Research Meeting from October 1-3, 2015. The theme of the meeting will be the scientific basis for eliminating malaria as a public health problem in Brazil. The meeting seeks to explore different aspects of human malaria and related experimental models, including new approaches and challenges to control, immunological and molecular determinants of pathogenesis, and new advancements in diagnosis and treatment, especially in the post-genome era. For more information, visit the meeting website.

Latest News.

  • Closing Ceremony for the Colombia Malaria Project
  • World Malaria Day 2015
  • Malaria Partners' Meeting and XIV AMI/RAVREDA Annual Evaluation Meeting
  • Haiti Malaria Elimination Consortium (HaMEC) Is Formed
  • XIV National Malaria Research Meeting in Brazil

April 25, 2015
Description: After five years of work, the Colombia Malaria Project came to an end. At the formal closing ceremony in Bogotá, responsibility for institutionalizing the achievements and lessons learned, as well as sustaining efforts against malaria to overcome challenges, was transferred to the Ministry of Health and Social Protection (MSPS), the National Institute of Health (INS), and the territorial entities, with support from AMI/RAVREDA partners. Read the news release and watch interviews with the former project manager, government officials, and PAHO/WHO advisors here (In Spanish).

April 25, 2015
Description: The Amazon Malaria Initiative (AMI) recognizes the need for more research on malaria in pregnancy in Latin America and the Caribbean. The US Centers for Disease Control and Prevention (CDC) estimate that 4 in 100 pregnancies in the region are affected by malaria. The negative effects of malaria in pregnancy include prematurity, low birth weight, miscarriages, stillbirth, and congenital malaria in infants. In addition, malaria in pregnant women can result in anemia, an increased risk of severe malaria, and even death. As most of the region has a low incidence of malaria, intermittent preventive treatment in pregnancy (IPTp) is not recommended in Latin America and the Caribbean.


Detecting and treating malaria in pregnant women is important in order to defeat malaria in Latin America and the Caribbean. AMI partners such as the CDC recommend that pregnant women be screened for malaria at each antenatal care visit. Pregnant women who are diagnosed with malaria should receive differentiated treatment according to the treatment guidelines of each country. As with the general population, prompt and effective diagnosis is encouraged along with the use of insecticide-treated bed nets.


AMI has developed a set of region specific Strategic Orientation Documents with guidelines for malaria. The Strategic Orientation Documents cover the topics of drug resistance monitoring in low-incidence settings, vector control, pharmaceutical management, and medicine quality control. They can be found on the AMI Resources page and on the PAHO website. Click Here.

March 23-26, 2015
Location: Rio de Janeiro, Brazil
Description: The Pan American Health Organization, in coordination with the Ministry of Health of Brazil, will host the annual AMI/RAVREDA international partners' meeting in Rio de Janeiro from March 24-26, 2015. The meeting's purpose is to review progress, lessons learned, and the implementation of tools developed by AMI/RAVREDA partners. Malaria-endemic countries' ministries of health that are on the frontlines of regional efforts against malaria will be present. Representatives of the United States Agency for International Development (USAID), US Centers for Disease Control and Prevention (CDC), US Pharmacopeial Convention (USP), the USAID-funded Systems for Improved Access to Pharmaceuticals and Services Program (SIAPS), and Links Media will attend on behalf of AMI/RAVREDA. Prior to the official opening, a Malaria Partners' Meeting is also planned with other entities such as the Mexican Agency for International Development Cooperation (AMEXCID), the Clinton Health Access Initiative (CHAI), Global Fund to Fight AIDS, TB, and Malaria, the Haiti Malaria Elimination Consortium (HaMEC), IS Global, and Population Services International (PSI).

February 26, 2015
Description: The Bill and Melinda Gates Foundation has awarded a $29.9 million grant to the US Centers for Disease Control and Prevention to lead the new Haiti Malaria Elimination Consortium (HaMEC). HaMEC's objective will be to eliminate malaria from the island of Hispaniola by 2020. Eight other institutions make up the consortium. "We laud this expression of solidarity with efforts to eliminate malaria from the only two countries in the Caribbean [Haiti and the Dominican Republic] where transmission still exists..." said Dr. Keith Carter, Senior Advisor on Malaria and other Communicable Diseases with the Pan American Health Organization/World Health Organization, a consortium partner.

February 2015
Location: Sao Paulo, Brazil
Description: Brazil will host its XIV National Malaria Research Meeting from October 1-3, 2015. The theme of the meeting will be the scientific basis for eliminating malaria as a public health problem in Brazil. The meeting seeks to explore different aspects of human malaria and related experimental models, including new approaches and challenges to control, immunological and molecular determinants of pathogenesis, and new advancements in diagnosis and treatment, especially in the post-genome era. For more information, visit the meeting website.

Malaria-Related News
AMI's Events Calendar

News archive

Last updated on: 7/28/2015